Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HXG4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 82 | 86 | PF00656 | 0.731 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.811 |
CLV_PCSK_PC1ET2_1 | 69 | 71 | PF00082 | 0.725 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.759 |
DEG_MDM2_SWIB_1 | 7 | 14 | PF02201 | 0.783 |
DOC_CKS1_1 | 120 | 125 | PF01111 | 0.746 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.769 |
DOC_USP7_MATH_1 | 90 | 94 | PF00917 | 0.646 |
DOC_USP7_UBL2_3 | 20 | 24 | PF12436 | 0.723 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.746 |
LIG_14-3-3_CanoR_1 | 28 | 35 | PF00244 | 0.706 |
LIG_14-3-3_CanoR_1 | 56 | 62 | PF00244 | 0.729 |
LIG_14-3-3_CanoR_1 | 70 | 75 | PF00244 | 0.597 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.761 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.676 |
LIG_BRCT_BRCA1_1 | 70 | 74 | PF00533 | 0.740 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.638 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.780 |
LIG_LIR_Apic_2 | 33 | 38 | PF02991 | 0.777 |
LIG_LIR_Gen_1 | 106 | 116 | PF02991 | 0.734 |
LIG_LIR_Nem_3 | 94 | 100 | PF02991 | 0.740 |
LIG_Pex14_2 | 3 | 7 | PF04695 | 0.754 |
LIG_PTB_Apo_2 | 36 | 43 | PF02174 | 0.544 |
LIG_PTB_Phospho_1 | 36 | 42 | PF10480 | 0.547 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.773 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.762 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.654 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.744 |
LIG_SH2_GRB2like | 35 | 38 | PF00017 | 0.765 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.762 |
LIG_SH2_SRC | 35 | 38 | PF00017 | 0.765 |
LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.709 |
LIG_SH2_STAT3 | 127 | 130 | PF00017 | 0.867 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.742 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.682 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.780 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.596 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.760 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.786 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.777 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.767 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.793 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.784 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.651 |
MOD_N-GLC_1 | 79 | 84 | PF02516 | 0.750 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.733 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.723 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.648 |
MOD_PIKK_1 | 103 | 109 | PF00454 | 0.662 |
MOD_PK_1 | 44 | 50 | PF00069 | 0.703 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.791 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.745 |
TRG_DiLeu_BaEn_1 | 25 | 30 | PF01217 | 0.795 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.644 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.775 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.758 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IAS9 | Leishmania donovani | 99% | 100% |
A4H950 | Leishmania braziliensis | 53% | 89% |
E9AR59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4QEA4 | Leishmania major | 90% | 100% |